DelveInsight Launching Gene Therapy Reports Highlighting 15 Therapy Areas

DelveInsight Gene therapy report highlights the profiles of Industry collective pipeline of 300+ Gene Therapies with prediction of early market winners using DelveInsight Competitive Matrix model.

New Delhi, India, January 15, 2015 --( DelveInsight, a Market Research & Business Consulting firm, is proud to announce the launch of their Gene Therapy Report: “Gene Therapy Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape.” The report uncovers the potential of global Gene Therapy Market with insights into 15 Therapy Areas with a collective pipeline of more than 300 gene therapies and the companies at their forefront.

DelveInsight Gene Therapy reports provides complete information across the gene therapy value chain covering gene therapy profile’s core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The report also analyses and investigates the current market trends and drivers of gene therapy. Moreover, DelveInsight’s propriety Competitive Matrix model describes the first in class market analytics. It provides predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view.

These report are an outcome of excellent analytical abilities, extensive research and prudent analysis of the global gene therapy market which provides complete insight over therapy areas like; Oncology, Central nervous system, Genetic Disorders, Haematological disorders, Metabolic disorders, Ophthalmology, Cardiovascular disease, Respiratory, Immunology and other therapy areas.

The client can go for a yearly subscription of quarterly updated report, only by paying USD 500 in addition to the report cost.

For more information on these Reports and Sample Pages please mail at
Isharpal Singh
+91-11-4568 9769